Technology

Tonix Pharmaceuticals

$1.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+5.10%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TNXP and other stocks, options, and ETFs commission-free!

About TNXP

Tonix Pharmaceuticals Holding Corp. Common Stock, also called Tonix Pharmaceuticals, is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY. The listed name for TNXP is Tonix Pharmaceuticals Holding Corp. Common Stock.

CEO
Seth Lederman
Employees
16
Headquarters
Chatham, New Jersey
Founded
2007
Market Cap
258.47M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
60.04M
High Today
$1.07
Low Today
$0.965
Open Price
$0.965
Volume
36.30M
52 Week High
$2.46
52 Week Low
$0.3902

Collections

TNXP Earnings

-$5.69
-$3.79
-$1.90
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, Pre-Market

You May Also Like

BWMX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure